Inhibitex shingles drug fails in mid-stage trial

O) experimental drug to treat shingles failed to meet the main goal of a mid-stage trial, sending its shares down 17 percent. There was a "numerically ...
See all stories on this topic

Source: Google Alerts - Shingles